메뉴 건너뛰기




Volumn 5, Issue 11, 2016, Pages

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

Author keywords

antimicrobial susceptibility testing; drug repositioning; drug repurposing; Klebsiella pneumoniae; multidrug resistant bacteria; targeted drug combination; ultra high throughput screen

Indexed keywords

ANTIBIOTIC AGENT; ARTESUNATE; AURANOFIN; AUROTHIOGLUCOSE; AZTREONAM; BLEOMYCIN; CARUMONAM; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; DEMECLOCYCLINE; DIBROMPROPAMIDINE; DOXYCYCLINE; FLORFENICOL; GENTAMICIN; HEXACHLOROPHENE; IMIPENEM; MECLOCYCLINE; OXYTETRACYCLINE; PHENYLMERCURIC ACETATE; PHENYLMERCURIC BORATE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PYRITHIONE ZINC; RIFABUTIN; SITAFLOXACIN; THIOMERSAL; TRIMETHOPRIM; ZIDOVUDINE; ANTIINFECTIVE AGENT; ANTIRHEUMATIC AGENT; DRUG COMBINATION;

EID: 84994545402     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2016.123     Document Type: Article
Times cited : (61)

References (51)
  • 1
    • 84979705347 scopus 로고    scopus 로고
    • Atlanta, GA: CDC, ; (accessed on 15 June 2016)
    • Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: CDC, 2016; Available at http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed on 15 June 2016).
    • (2016) Antibiotic Resistance Threats in the United States, 2013
  • 2
    • 10944272743 scopus 로고    scopus 로고
    • Antibacterial resistance worldwide: Causes, challenges and responses
    • Dec.
    • Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004 Dec; 10(12 Suppl): S122-S129.
    • (2004) Nat Med , vol.10 , Issue.12 , pp. S122-S129
    • Levy, S.B.1    Marshall, B.2
  • 3
    • 72849135301 scopus 로고    scopus 로고
    • Antimicrobial susceptibility testing: A review of general principles and contemporary practices
    • Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis 2009; 149: 1749-1755.
    • (2009) Clin Infect Dis , vol.149 , pp. 1749-1755
    • Jorgensen, J.H.1    Ferraro, M.J.2
  • 4
    • 84875261410 scopus 로고    scopus 로고
    • Combination approaches to combat multidrug-resistant bacteria
    • Mar.
    • Worthington RJ, Melander C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 2013 Mar; 31: 177-184.
    • (2013) Trends Biotechnol , vol.31 , pp. 177-184
    • Worthington, R.J.1    Melander, C.2
  • 5
    • 84911003547 scopus 로고    scopus 로고
    • Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: A systematic review
    • Poulikakos P, Tansarli GS, Falagas ME. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis 2014; 33: 1675-1685.
    • (2014) Eur J Clin Microbiol Infect Dis , vol.33 , pp. 1675-1685
    • Poulikakos, P.1    Tansarli, G.S.2    Falagas, M.E.3
  • 6
    • 84926343938 scopus 로고    scopus 로고
    • Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: A retrospective cohort study
    • Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 2014; 18: 6.
    • (2014) Crit Care , vol.18 , pp. 6
    • Zilberberg, M.D.1    Shorr, A.F.2    Micek, S.T.3    Vazquez-Guillamet, C.4    Kollef, M.H.5
  • 7
    • 84983591272 scopus 로고    scopus 로고
    • Verification of an automated, digital dispensing platform for at-will broth microdilution antimicrobial susceptibility testing
    • Smith KP, Kirby JE. Verification of an automated, digital dispensing platform for at-will broth microdilution antimicrobial susceptibility testing. J Clin Microbiol 2016; 54: 2288-2293.
    • (2016) J Clin Microbiol , vol.54 , pp. 2288-2293
    • Smith, K.P.1    Kirby, J.E.2
  • 9
    • 34249901630 scopus 로고    scopus 로고
    • Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis
    • Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 2006; 10: R111.
    • (2006) Crit Care , vol.10 , pp. R111
    • Garnacho-Montero, J.1    Aldabo-Pallas, T.2    Garnacho-Montero, C.3
  • 10
    • 84948709890 scopus 로고    scopus 로고
    • Antibiotic resistance breakers: Can repurposed drugs fill the antibiotic discovery void?
    • Brown D. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? Nat Rev Drug Discov 2015; 14: 821-832.
    • (2015) Nat Rev Drug Discov , vol.14 , pp. 821-832
    • Brown, D.1
  • 11
    • 16644367566 scopus 로고    scopus 로고
    • Antimicrobial drug development - The past, the present, and the future
    • Powers JH. Antimicrobial drug development - the past, the present, and the future. Clin Microbiol Infec 2004; 10: 23-31.
    • (2004) Clin Microbiol Infec , vol.10 , pp. 23-31
    • Powers, J.H.1
  • 12
    • 84865574615 scopus 로고    scopus 로고
    • Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms
    • Chromy BA, Elsheikh M, Christensen TL et al. Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms. Future Microbiol 2012; 7: 1011-1020.
    • (2012) Future Microbiol , vol.7 , pp. 1011-1020
    • Chromy, B.A.1    Elsheikh, M.2    Christensen, T.L.3
  • 13
    • 84903757348 scopus 로고    scopus 로고
    • Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
    • Feng J, Wang T, Shi WL et al. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect 2014; 3: e49.
    • (2014) Emerg Microbes Infect , vol.3 , pp. e49
    • Feng, J.1    Wang, T.2    Shi, W.L.3
  • 14
    • 84928920149 scopus 로고    scopus 로고
    • Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
    • Harbut MB, Vilcheze C, Luo X et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci USA 2015; 7112: 4453-4458.
    • (2015) Proc Natl Acad Sci USA , vol.7112 , pp. 4453-4458
    • Harbut, M.B.1    Vilcheze, C.2    Luo, X.3
  • 15
    • 84985947120 scopus 로고    scopus 로고
    • Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and drug administration-approved antibiotics, 2010-2015
    • Deak D, Outterson K, Powers JH, Kesselheim AS. Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015. Ann Intern Med 2016; 165: 363-372.
    • (2016) Ann Intern Med , vol.165 , pp. 363-372
    • Deak, D.1    Outterson, K.2    Powers, J.H.3    Kesselheim, A.S.4
  • 16
    • 79955428497 scopus 로고    scopus 로고
    • The NCGC pharmaceutical collection: A comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics
    • Huang RL, Southall N, Wang YH et al. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med 2011; 3: 80ps16.
    • (2011) Sci Transl Med , vol.3 , pp. 80ps16
    • Huang, R.L.1    Southall, N.2    Wang, Y.H.3
  • 17
    • 77950397958 scopus 로고    scopus 로고
    • Lateral patch-clamping in a standard 1536-well microplate format
    • Tang KC, Reboud J, Kwok YL, Peng SL, Yobas L. Lateral patch-clamping in a standard 1536-well microplate format. Lab Chip 2010; 10: 1044-1050.
    • (2010) Lab Chip , vol.10 , pp. 1044-1050
    • Tang, K.C.1    Reboud, J.2    Kwok, Y.L.3    Peng, S.L.4    Yobas, L.5
  • 18
    • 67649997684 scopus 로고    scopus 로고
    • Microfractionation revisited: A 1536 well high resolution screening assay
    • Giera M, Heus F, Janssen L, Kool J, Lingeman H, Irth H. Microfractionation revisited: a 1536 well high resolution screening assay. Anal Chem 2009; 181: 5460-5466.
    • (2009) Anal Chem , vol.181 , pp. 5460-5466
    • Giera, M.1    Heus, F.2    Janssen, L.3    Kool, J.4    Lingeman, H.5    Irth, H.6
  • 19
    • 84943756669 scopus 로고    scopus 로고
    • Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10 K library
    • Chen S, Hsieh JH, Huang R et al. Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10 K library. Toxicol Sci 2015; 147: 446-457.
    • (2015) Toxicol Sci , vol.147 , pp. 446-457
    • Chen, S.1    Hsieh, J.H.2    Huang, R.3
  • 20
    • 33746789921 scopus 로고    scopus 로고
    • Quantitative high-throughput screening: A titrationbased approach that efficiently identifies biological activities in large chemical libraries
    • Inglese J, Auld DS, Jadhav A et al. Quantitative high-throughput screening: a titrationbased approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci USA 2006; 1103: 11473-11478.
    • (2006) Proc Natl Acad Sci USA , vol.1103 , pp. 11473-11478
    • Inglese, J.1    Auld, D.S.2    Jadhav, A.3
  • 21
    • 84979609071 scopus 로고    scopus 로고
    • Horizontal transfer of carbapenemase-encoding plasmids and comparison with hospital epidemiology data
    • Hardiman CA, Weingarten RA, Conlan S et al. Horizontal transfer of carbapenemase-encoding plasmids and comparison with hospital epidemiology data. Antimicrob Agents Chemother 2016; 60: 4910-4919.
    • (2016) Antimicrob Agents Chemother , vol.60 , pp. 4910-4919
    • Hardiman, C.A.1    Weingarten, R.A.2    Conlan, S.3
  • 22
    • 79955428497 scopus 로고    scopus 로고
    • The NCGC pharmaceutical collection: A comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics
    • Huang R, Southall N, Wang Y et al. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med 2011; 3: 80ps16.
    • (2011) Sci Transl Med , vol.3 , pp. 80ps16
    • Huang, R.1    Southall, N.2    Wang, Y.3
  • 23
    • 84906754009 scopus 로고    scopus 로고
    • Chemical signatures and new drug targets for gametocytocidal drug development
    • Sun W, Tanaka TQ, Magle CT et al. Chemical signatures and new drug targets for gametocytocidal drug development. Sci Rep 2014; 4: 3743.
    • (2014) Sci Rep , vol.4 , pp. 3743
    • Sun, W.1    Tanaka, T.Q.2    Magle, C.T.3
  • 26
    • 84882667253 scopus 로고    scopus 로고
    • Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens
    • Sun W, Park YD, Sugui JA et al. Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens. Plos ONE 2013; 8: e70506.
    • (2013) Plos ONE , vol.8 , pp. e70506
    • Sun, W.1    Park, Y.D.2    Sugui, J.A.3
  • 27
    • 69249213919 scopus 로고    scopus 로고
    • A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-A-go-go-related gene channel
    • Titus SA, Beacham D, Shahane SA et al. A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. Anal Biochem 2009; 1394: 30-38.
    • (2009) Anal Biochem , vol.1394 , pp. 30-38
    • Titus, S.A.1    Beacham, D.2    Shahane, S.A.3
  • 28
    • 0033047893 scopus 로고    scopus 로고
    • Oxidant mechanisms in gentamicin nephrotoxicity
    • Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 1999; 21: 433-442.
    • (1999) Ren Fail , vol.21 , pp. 433-442
    • Walker, P.D.1    Barri, Y.2    Shah, S.V.3
  • 30
    • 84954287879 scopus 로고    scopus 로고
    • Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections
    • Aguinagalde L, Diez-Martinez R, Yuste J et al. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections. J Antimicrob Chemother 2015; 70: 2608-2617.
    • (2015) J Antimicrob Chemother , vol.70 , pp. 2608-2617
    • Aguinagalde, L.1    Diez-Martinez, R.2    Yuste, J.3
  • 31
    • 84882598507 scopus 로고    scopus 로고
    • Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: A breakpoint artefact?
    • Schon T, Jureen P, Chryssanthou E et al. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact? J Antimicrob Chemother 2013; 68: 2074-2077.
    • (2013) J Antimicrob Chemother , vol.68 , pp. 2074-2077
    • Schon, T.1    Jureen, P.2    Chryssanthou, E.3
  • 32
    • 84927644630 scopus 로고    scopus 로고
    • Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
    • He S, Lin B, Chu V et al. Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection. Sci Transl Med 2015; 7: 282ra249.
    • (2015) Sci Transl Med , vol.7 , pp. 282ra249
    • He, S.1    Lin, B.2    Chu, V.3
  • 33
    • 0001707601 scopus 로고
    • 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
    • Mitsuya H, Weinhold KJ, Furman PA et al. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82: 7096-7100.
    • (1985) Proc Natl Acad Sci USA , vol.82 , pp. 7096-7100
    • Mitsuya, H.1    Weinhold, K.J.2    Furman, P.A.3
  • 34
    • 84908399993 scopus 로고    scopus 로고
    • Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate
    • Lisewski AM, Quiros JP, Ng CL et al. Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate. Cell 2014; 158: 916-928.
    • (2014) Cell , vol.158 , pp. 916-928
    • Lisewski, A.M.1    Quiros, J.P.2    Ng, C.L.3
  • 35
    • 0038147060 scopus 로고    scopus 로고
    • Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit
    • Jeon KI, Byun MS, Jue DM. Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med 2003; 35: 61-66.
    • (2003) Exp Mol Med , vol.35 , pp. 61-66
    • Jeon, K.I.1    Byun, M.S.2    Jue, D.M.3
  • 36
    • 0039798749 scopus 로고
    • Light-dependent volume changes and reactions in chloroplasts. I. Action of alkenylsuccinic acids and phenylmercuric acetate and possible relation to mechanisms of stomatal control
    • Siegenthaler PA, Packer L. Light-dependent volume changes and reactions in chloroplasts. I. Action of alkenylsuccinic acids and phenylmercuric acetate and possible relation to mechanisms of stomatal control. Plant Physiol 1965; 40: 785-791.
    • (1965) Plant Physiol , vol.40 , pp. 785-791
    • Siegenthaler, P.A.1    Packer, L.2
  • 38
    • 0017548298 scopus 로고
    • DNA double-strand breaks and alkali-labile bonds produced by bleomycin
    • Povirk LF, Wubter W, Kohnlein W, Hutchinson F. DNA double-strand breaks and alkali-labile bonds produced by bleomycin. Nucleic Acids Res 1977; 4: 3573-3580.
    • (1977) Nucleic Acids Res , vol.4 , pp. 3573-3580
    • Povirk, L.F.1    Wubter, W.2    Kohnlein, W.3    Hutchinson, F.4
  • 39
    • 0016242923 scopus 로고
    • Antimicrobial actions of hexachlorophene: Inhibition of respiration in Bacillus megaterium
    • Frederick JJ, Corner TR, Gerhardt P. Antimicrobial actions of hexachlorophene: inhibition of respiration in Bacillus megaterium. Antimicrob Agents Chemother 1974; 6: 712-721.
    • (1974) Antimicrob Agents Chemother , vol.6 , pp. 712-721
    • Frederick, J.J.1    Corner, T.R.2    Gerhardt, P.3
  • 40
    • 0017815548 scopus 로고
    • Tetracyclines: New look at old antibiotic. I. Clinical pharmacology, mechanism of action, and untoward effects
    • Siegel D. Tetracyclines: new look at old antibiotic. I. Clinical pharmacology, mechanism of action, and untoward effects. NY State J Med 1978; 78: 950-956.
    • (1978) NY State J Med , vol.78 , pp. 950-956
    • Siegel, D.1
  • 41
    • 84858627056 scopus 로고    scopus 로고
    • Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens
    • Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56: 2108-2113.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 2108-2113
    • Qureshi, Z.A.1    Paterson, D.L.2    Potoski, B.A.3
  • 42
    • 77949569493 scopus 로고    scopus 로고
    • Antibiotic resistance and its cost: Is it possible to reverse resistance?
    • Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 2010; 8: 260-271.
    • (2010) Nat Rev Microbiol , vol.8 , pp. 260-271
    • Andersson, D.I.1    Hughes, D.2
  • 43
    • 84971672804 scopus 로고    scopus 로고
    • Drug combination therapy increases successful drug repositioning
    • Sun W, Sanderson P, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today 2016; 21: 1189-1195.
    • (2016) Drug Discov Today , vol.21 , pp. 1189-1195
    • Sun, W.1    Sanderson, P.2    Zheng, W.3
  • 44
    • 84925498076 scopus 로고    scopus 로고
    • Auranofin: Repurposing an old drug for a golden new age
    • Roder C, Thomson MJ. Auranofin: repurposing an old drug for a golden new age. Drugs R D 2015; 15: 13-20.
    • (2015) Drugs R D , vol.15 , pp. 13-20
    • Roder, C.1    Thomson, M.J.2
  • 46
    • 84880379313 scopus 로고    scopus 로고
    • Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: A multicenter, randomized clinical trial
    • Durante-Mangoni E, Signoriello G, Andini R et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clinical Infectious Diseases 2013; 57: 349-358.
    • (2013) Clinical Infectious Diseases , vol.57 , pp. 349-358
    • Durante-Mangoni, E.1    Signoriello, G.2    Andini, R.3
  • 47
    • 84910127305 scopus 로고    scopus 로고
    • When does 2 plus 2 equal 5? A review of antimicrobial synergy testing
    • Doern CD. When does 2 plus 2 equal 5? a review of antimicrobial synergy testing. J Clin Microbiol 2014; 52: 4124-4128.
    • (2014) J Clin Microbiol , vol.52 , pp. 4124-4128
    • Doern, C.D.1
  • 48
    • 23444457294 scopus 로고    scopus 로고
    • Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: A randomised, double-blind, controlled clinical trial
    • Aaron SD, Vandemheen KL, Ferris W et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Lancet 2005; 366: 463-471.
    • (2005) Lancet , vol.366 , pp. 463-471
    • Aaron, S.D.1    Vandemheen, K.L.2    Ferris, W.3
  • 49
    • 34548833833 scopus 로고    scopus 로고
    • Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms
    • Aaron SD. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms. Paediatr Respir Rev 2007; 8: 256-261.
    • (2007) Paediatr Respir Rev , vol.8 , pp. 256-261
    • Aaron, S.D.1
  • 50
    • 84971277787 scopus 로고    scopus 로고
    • Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): A study protocol
    • Dickstein Y, Leibovici L, Yahav D et al. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol. BMJ Open 2016; 6: e009956.
    • (2016) BMJ Open , vol.6 , pp. e009956
    • Dickstein, Y.1    Leibovici, L.2    Yahav, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.